Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EMA Reviewing Guide To Support New Genome Editing Technologies, CAR-T Cell Therapies

Executive Summary

The European Medicines Agency is updating its five-year old guideline on drugs containing genetically modified cells to factor in rapid scientific developments in relation to gene editing technologies, and the development of promising new cancer immunotherapies, such as CAR-T cells.

You may also be interested in...



EMA’s Advanced Therapies Panel To Set Up Medtech Group

The 2020 work plan of the European Medicines Agency’s Committee on Advanced Therapies includes initiatives to support the implementation of the EU regulations on medical devices and IVDs. 

EU Guides On ATMP Trials, Genetically Modified Cells To Be Finalized This Year

The 2020 work plan of the European Medicines Agency’s committee on advanced therapies shows that two keenly-awaited guidelines are due to be finalized this year.

CAR-T Cells Addressed In Updated EMA Guide On Drugs Containing Genetically-Modified Cells

The European Medicines Agency's current thinking on the clinical development of CAR-T cells is outlined in a new annex.

Related Content

Topics

UsernamePublicRestriction

Register

PS121176

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel